PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Warwick Medical School, University of Warwick, Warwick, UK; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.\', \'Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London, UK.\', \'Melanoma Institute Australia and The University of Sydney, Sydney, Australia; Royal North Shore and Mater Hospitals, Sydney, Australia.\', \'Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK; Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: samra.turajlic@crick.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0923-7534(21)01078-410.1016/j.annonc.2021.03.199
?:hasPublicationType
?:journal
  • Annals of oncology : official journal of the European Society for Medical Oncology
is ?:pmid of
?:pmid
?:pmid
  • 33771665
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Immunotherapy use outside clinical trial populations: never say never?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all